Pivotal Device Studies in Brazil

Clinical Trials in: Mexico, Argentina, Colombia and Brazil.

Locally-Based, Full Service CRO

Contact us today to learn more.

+ 0
Sites Throughout LATAM
+ 200
Patients in our network
+ 0
Conducted Studies
0 %
Lost-to-Follow Up rate
As a leading CRO in LATAM, we specialize in supporting clinical trials throughout the region. Our extensive experience and broad network of clinical sites enable us to execute trials with speed and efficiency, ensuring high patient recruitment and retention rates.

Clinical Trials Emerging Market in Brazil

Pivotal Device Studies in Brazil – Advantages of Clinical Trials

In the dynamic world of medical research and healthcare advancement, Brazil has emerged as a prominent player in driving pivotal device studies that have the potential to reshape patient care and revolutionize the medical landscape.

This blog delves into the significance of pivotal device studies in Brazil, highlighting how the country’s unique attributes contribute to the progress of healthcare and the enhancement of lives on a global scale.

Pivotal Device Studies: A Cornerstone of Medical Evolution

Pivotal device studies represent a pivotal phase in the development of medical devices, offering a comprehensive evaluation of their safety, efficacy, and potential advantages. These studies act as a vital link between groundbreaking innovations and their integration into mainstream healthcare practices, ensuring that novel devices meet stringent standards before they become accessible to patients.

Brazil’s Healthcare Landscape: Nurturing Ground for Innovation

Brazil’s healthcare sector has undergone remarkable transformations, positioning the nation as a promising hub for medical research and pivotal device studies.

With a network of state-of-the-art medical facilities, highly skilled healthcare professionals, and a diverse patient demographic, Brazil provides an ideal environment for conducting clinical trials and device studies. Its strategic position in South America further solidifies its standing as a pivotal destination for cutting-edge medical research.

Advantages of Pivotal Device Studies in Brazil

  1. Diverse Patient Demographics: Brazil boasts a population that spans a wide spectrum of ethnicities, cultures, and socioeconomic backgrounds. This diversity translates into a rich pool of participants for pivotal studies, ensuring that the outcomes are more representative and applicable to a global context.
  2. Cost-Effective Research: The conduct of medical research and clinical trials in Brazil often comes with lower costs compared to more developed nations. This cost-effectiveness can streamline research timelines, making pivotal device studies more efficient and accessible.
  3. Favorable Regulatory Climate: Brazil’s regulatory framework for medical device studies has evolved to align with international standards, creating an enabling environment for the execution of pivotal studies. Streamlined approval processes facilitate the seamless progression of research, allowing innovative devices to reach the market more expeditiously.
  4. Collaborative Opportunities: Pivotal device studies in Brazil often involve collaboration between local experts, research institutions, and international collaborators. This collaborative approach fosters the exchange of knowledge, the sharing of best practices, and enriches the overall research ecosystem.

Pivotal Device Studies in Brazil

Pivotal Device Studies in Brazil

Pivotal Device Studies in Brazil

Notable Pivotal Device Studies in Brazil

Brazil has hosted several groundbreaking device studies that have significantly impacted medical research. One such study focused on advanced prosthetics, exploring the integration of state-of-the-art materials and sensory feedback mechanisms. The study showcased the potential of these prosthetics in restoring mobility and enhancing the quality of life for amputees.

In the realm of cardiovascular health, Brazil played a pivotal role in a study involving innovative stent technologies for the treatment of coronary artery disease. The study’s findings highlighted the feasibility and safety of these cutting-edge stents, offering a minimally invasive alternative for patients with cardiac conditions.

Shaping the Future of Healthcare in Brazil

Pivotal device studies in Brazil are poised to shape the future of healthcare within the nation and beyond. As these studies continue to flourish, Brazil’s healthcare landscape stands to benefit from improved medical devices that have undergone rigorous evaluation, ensuring their effectiveness and safety.

In conclusion, Brazil’s contribution to pivotal device studies underscores its dedication to advancing healthcare through innovation. With its diverse patient population, cost-effective research opportunities, favorable regulatory environment, and collaborative spirit, Brazil is primed to lead the way in the adoption of novel medical technologies.

As we celebrate the achievements of pivotal device studies in Brazil, we eagerly anticipate the transformative impact they will have on healthcare and the well-being of countless individuals.

Pivotal Device Studies in Brazil

Source: Duke Clinical Research Institute

Welcome to Cohortias!

of Latin America

Simplify Your Clinical Trials with Our Expert Infrastructure in Latin America

Say goodbye to the complex, costly, and disorganized process of conducting clinical trials. Our infrastructure in Latin America streamlines the launch of studies and ensures adherence to international standards. Schedule a call with us today to discover the path to simplified clinical research in Latin America.

Pivotal Device Studies in Brazil

Explore What We Are Doing Better

We define ourselves as a unique team, capable of blending our academic background with a global business mindset to bring the highest standard of quality and operational excellence into clinical research in Latin America.

Early Phase Trials

- First-in-Human Studies.
- Get to patients faster, no IND necessary.
- Valid data for FDA submission.

Rescue Studies

- Regain lost time and boost patient recruitment.
- We work alongside Global CROs to get studies back on track.
- More than 200 sites available.

Phase II & III Trials

- Full-Service Clinical Outsourcing.
- Proven infrastructure that can handle any trial.
- Local Regulatory Experts
- Wide network of sites and physicians.

Medical Devices

- A fast-track platform that will meet your timeline.
- We take care of everything, from shipping requirements all the way to data collection.
Pivotal Device Studies in Brazil

Full Service CRO in LATAM

Outsourcing Clinical Trials to Latin America

Unlock the advantages and opportunities of outsourcing clinical trials to Latin America. Diverse patient population, streamlined regulations, and cost-effectiveness

Lower Operating Costs

From lower labor costs to lower costs for rent, utilities, and equipment, you can save money on your clinical trial budget while still ensuring the quality of your trial

Access to Emerging Markets

Latin America offers access to emerging markets, providing an opportunity for pharmaceutical companies to expand their reach and reach new patient populations.

Pivotal Device Studies in Brazil

Cohortias is redefining Clinical Research in Latin America

We are committed to become leaders in providing clinical research services in Latin America. Here at Cohortias, we combine our academic roots, proven experience and a large pool of patients from an extensive network of sites.

Our main purpose is to deliver high quality data.

Pivotal Device Studies in Brazil

Clinical Research in Latin America

Cohortias has built an extensive and highly reputable network of clinical sites which can access patients in a timely manner and operate within a standard-of-care comparable to the U.S. healthcare system.


  • Site Management

  • Data Management

  • Site Selection

  • Regulatory Submissions

  • Clinical Monitoring

  • Protocol Development


Beta Trials Platform

  • First-in-human studies

Medical Devices

  • Pilot and Pivotal Device Studies

Phases I – III

  • We partner with our clients to bring their products in a fast and efficient manner to the market with the highest quality standards


  • Diabetes/Metabolic Syndromes
  • Infectious Diseases
  • Cardiovascular
  • Neurology
  • Respiratory
  • Oncology

Pivotal Device Studies in Brazil

Clinical Research in Latin America

Academic Leadership and Extensive Clinical Site Network for Efficient Clinical Trials

  • Our peer-to-peer management approach guarantees high patient recruitment and retention in any clinical trial

High Speed Execution

  • We offer the quickest start-up times in each country.
  • Efficient Clinical Site Selection and Contracting.
  • Benefit from our extensive network of clinical sites and streamlined contracting process.

Operational Excellence

  • Proven record of delivering rescue studies, we consistently exceed industry performance standards.
  • Our team provides efficient query resolution to keep your trial on track.

Business Insight and Flexibility

  • We offer innovative pricing models and short lines of communication to ensure maximum flexibility and cost-effectiveness.
  • At Cohortias, we prioritize  short lines of communication to ensure efficient collaboration.
  • Swift adaptation to changes in the trial landscape to keep your study on schedule.

Pivotal Device Studies in Brazil

We provide our services with offices in:

Colombia &

Daniela Maresca
Daniela Maresca | Country Lead Argentina
Martín Hernández-Torre | CMO
Maritza Rojas | CRA II
Pedro Alvarez | Business Development Manager
Samantha Rodriguez Cohortias
Samantha Rdz. | Start-Up Manager
Pivotal Device Studies in Brazil

The Cohortias Team

Pivotal Device Studies in Brazil

As the largest South American Contract research Organization, we know the Advantages and Challenges Of the Region

Let Us Guide You Through The Latin American Clinical Research Landscape

Pivotal Device Studies in Brazil

Network & Partnerships